Be a part of Medical Revolution break-through with Innovation Driven Medical Technology using Cannabis for Treatment of Cancer, Multiple Sclerosis, Epilepsy, HIV/AIDS, Post-Traumatic Stress Disorder and many more chronic diseases.
The Company through its Medical Research Institute has successfully modified & re-engineered the Cannabis plant. The genetically modified plant enhances properties of the Cannabis to be used for medical purpose.
• Project Conceptualization Started<br />
<br />
• Corporation with various blockchain specialist, advisors to form strategic alliance<br />
<br />
• Form Strategic Alliance with other Medical Cannabis Research and Cultivation companies<br />
2nd Half, 2018
• ICO - Pre-Sale & Institutional Sale<br />
<br />
• Pre- ICO 10% & ICO 50% of the coins will be distributed to expand EIMCR<br />
<br />
• Form strategic alliance with R&D departments in Universities in the area<br />
<br />
• Finalise discussions with Governmental figures<br />
1st Half, 2019
• Strategic Alliance with companies to produce MCan Products<br />
<br />
• Establishment of pharmaceutical manufacturing facilities<br />
<br />
• Production of MCan cultivation Begins <br />
2nd Half, 2019
• Adding more and the very best Consultants, Doctors and Scientists.<br />
<br />
• Medical Cannabis harvest<br />
<br />
• All Production of MCan Products Begins<br />
2020
• Aggressive expansion to 13 new countries<br />
<br />
• Expansion to new verticals, concrete plans set and teams ready to expand to 13 countries in 2 years.<br />
2021
• IPO (Initial Public Offering in major Global Exchanges)<br />
<br />
• NASDAQ, London Stock Exchange (LSE).<br />
<br />
• Further expansion & Global dominance<br />
<br />
• Aggressive marketing in current markets to 8 more new countries in 2 years.<br />
<br />
• Expansion of Manufacturing Facilities in few countries.<br />
<br />
• Blockchain era continues.<br />
.png)
